Privia Health will release third-quarter financial results on November 6, 2025, followed by a management conference call.
Quiver AI Summary
Privia Health Group, Inc. announced that it will release its financial results for the third quarter and the nine-month period ending September 30, 2025, before the market opens on November 6, 2025. The company will distribute the press release at 7:00 am ET and it will be accessible on their Investor Relations website. Privia Health management will hold a conference call at 8:00 am ET on the same day to discuss the financial results and provide an outlook for future performance. The call can be listened to via live webcast and will be available for replay afterward. Privia Health is a major physician enablement organization in the U.S., operating in 15 states and the District of Columbia, focused on improving healthcare delivery and patient experiences while supporting a large network of healthcare providers.
Potential Positives
- Privia Health Group is set to release its third-quarter and nine-month financial results on November 6, 2025, providing investors with timely insights into the company's performance.
- The management will host a conference call on the same day to discuss the financial results and outlook, demonstrating transparency and engagement with investors.
- Privia Health is recognized as one of the largest physician enablement companies in the U.S., indicating strong market presence and leadership in its sector.
- The company optimizes over 1,300 physician practices and improves healthcare delivery for over 5.3 million patients, highlighting its significant impact on the healthcare system.
Potential Negatives
- None
FAQ
When will Privia Health release its Q3 2025 financial results?
Privia Health is set to release its third-quarter financial results before market open on November 6, 2025.
What time is the Privia Health conference call?
The conference call will begin at 8:00 am ET on November 6, 2025.
How can I access the Privia Health earnings call?
You can listen to the earnings call via live webcast at ir.priviahealth.com/news-and-events/events-and-presentations.
Is the Privia Health webcast available for replay?
Yes, the webcast will be archived for on-demand listening shortly after the call's completion.
Who can I contact for more information about Privia Health?
For inquiries, you can reach Robert Borchert at [email protected] or call 817-783-4841.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PRVA Insider Trading Activity
$PRVA insiders have traded $PRVA stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $PRVA stock by insiders over the last 6 months:
- PARTH MEHROTRA (Chief Executive Officer) has made 0 purchases and 4 sales selling 62,147 shares for an estimated $1,487,343.
- MATTHEW SHAWN MORRIS sold 10,309 shares for an estimated $240,508
- DAVID MOUNTCASTLE (EVP & Chief Financial Officer) has made 0 purchases and 2 sales selling 6,767 shares for an estimated $163,388.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PRVA Hedge Fund Activity
We have seen 150 institutional investors add shares of $PRVA stock to their portfolio, and 110 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 3,981,833 shares (-22.2%) from their portfolio in Q2 2025, for an estimated $91,582,159
- WELLINGTON MANAGEMENT GROUP LLP removed 1,650,288 shares (-88.4%) from their portfolio in Q2 2025, for an estimated $37,956,624
- BANK OF AMERICA CORP /DE/ removed 1,353,571 shares (-52.8%) from their portfolio in Q2 2025, for an estimated $31,132,133
- VAN BERKOM & ASSOCIATES INC. added 887,549 shares (+44.1%) to their portfolio in Q2 2025, for an estimated $20,413,627
- SILVERCREST ASSET MANAGEMENT GROUP LLC added 674,411 shares (+117.8%) to their portfolio in Q2 2025, for an estimated $15,511,453
- RIVERBRIDGE PARTNERS LLC removed 569,799 shares (-10.3%) from their portfolio in Q2 2025, for an estimated $13,105,377
- FREESTONE GROVE PARTNERS LP added 540,722 shares (+inf%) to their portfolio in Q2 2025, for an estimated $12,436,606
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PRVA Analyst Ratings
Wall Street analysts have issued reports on $PRVA in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 09/24/2025
- JMP Securities issued a "Market Outperform" rating on 08/29/2025
- Piper Sandler issued a "Overweight" rating on 08/11/2025
- Evercore ISI Group issued a "Outperform" rating on 07/09/2025
- JP Morgan issued a "Overweight" rating on 05/28/2025
- Baird issued a "Outperform" rating on 04/15/2025
To track analyst ratings and price targets for $PRVA, check out Quiver Quantitative's $PRVA forecast page.
$PRVA Price Targets
Multiple analysts have issued price targets for $PRVA recently. We have seen 8 analysts offer price targets for $PRVA in the last 6 months, with a median target of $29.5.
Here are some recent targets:
- Jeff Garro from Stephens & Co. set a target price of $32.0 on 09/24/2025
- David M. Scharf from JMP Securities set a target price of $30.0 on 08/29/2025
- Sean Wieland from Piper Sandler set a target price of $36.0 on 08/11/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $28.0 on 07/09/2025
- Lisa Gill from JP Morgan set a target price of $32.0 on 05/28/2025
- Andrew Mok from Barclays set a target price of $24.0 on 05/27/2025
- Michael Ha from Baird set a target price of $26.0 on 04/15/2025
Full Release
ARLINGTON, Va., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, 2025 before market open on Thursday, November 6, 2025.
The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company’s Investor Relations website at ir.priviahealth.com . Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 6, to discuss the results and management’s outlook for future financial and operational performance.
You can visit ir.priviahealth.com/news-and-events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. To participate in the live conference call, dial 888-596-4144 (or 646-968-2525 for international callers) and provide Conference ID 5704885.
About Privia Health
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 15 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 5.3+ million patients, and reward 5,100+ physicians and advanced practitioners for delivering high-value care.
Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com .
Contact
Robert Borchert
SVP, Investor & Corporate Communications
[email protected]
817.783.4841
